SCHEMBL1945663

SCHEMBL1945663

Fc1ccc(-c2cn3nc(NCc4ccco4)sc3n2)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 5/20 0.43
SOS1 Q07889 1/20 0.42
KMT2A Q03164 6/20 0.42
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
F2RL3 Q96RI0 1/20 0.41
ALDH1A1 P00352 5/20 0.41
MAPT P10636 5/20 0.41
KDM4E B2RXH2 4/20 0.41
GAA P10253 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
F2 P00734 1/20 0.41
SMN1; SMN2 Q16637 6/20 0.40
HSD17B10 Q99714 4/20 0.40
TP53 P04637 4/20 0.40
MAPK1 P28482 3/20 0.40
MEN1 O00255 3/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1944387 0.86 F2RL3 (0.52) FYNKMT2ANPC1RAB9AF2RL3
SCHEMBL1944803 0.84 NR1H4 (0.48) FYNNPC1RAB9AF2RL3MAPT
SCHEMBL1945218 0.83 TP53 (0.53) FYNKMT2ANPC1RAB9AF2RL3
SCHEMBL1945114 0.83 FYN (0.44) FYNKMT2ANPC1RAB9AF2RL3
SCHEMBL1945451 0.82 F2RL3 (0.50) FYNKMT2ANPC1RAB9AF2RL3
SCHEMBL1944391 0.81 ALDH1A1 (0.61) FYNKMT2ANPC1RAB9AALDH1A1
SCHEMBL2255161 0.81 F2RL3 (0.42) FYNNPC1RAB9AF2RL3MAPT
SCHEMBL15603233 0.81 FYN (0.44) FYNNPC1RAB9AF2RL3MAPT
SCHEMBL1944633 0.80 MAPT (0.46) FYNNPC1RAB9AF2RL3MAPT
SCHEMBL1946565 0.80 ALDH1A1 (0.56) FYNKMT2ANPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307425-B1 IMIDAZOTHIADIAZOLES DERIVATIVES MERCK PATENT GMBH (DE) 2014-03-26 EP claimed
EP-2307425-B1 IMIDAZOTHIADIAZOLES DERIVATIVES MERCK PATENT GMBH (DE) 2014-03-26 EP disclosed
US-8389554-B2 Imidazothiadiazole derivatives MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 2013-03-05 US disclosed
US-20110130396-A1 IMIDAZOTHIADIAZOLE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130396-A1 IMIDAZOTHIADIAZOLE DERIVATIVES TGFBR1, TGFBR2, IGF1R FYN 1977/4885SOS1 1060/4885KMT2A 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.